3-acetylpyridine has been researched along with niacinamide in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (46.15) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 4 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marini, AM; Paul, SM; Weller, M | 1 |
| Beas-Zárate, C; Feria-Velasco, A; Morales-Villagran, A; Tapia-Arizmendi, G | 1 |
| Spector, R | 1 |
| Balaban, CD | 1 |
| Barbeau, A; Barbeau, CM; De Michele, G; Jolicoeur, FB | 1 |
| Morgan, PF; Stone, TW | 1 |
| Montarolo, PG; Raschi, F; Strata, P | 1 |
| Caston, J; Jones, N; Le Marec, N; Stelz, T | 1 |
| Aranda, A; Pascual, A; Perez, P; Sanchez-Pacheco, A; Villa, A | 1 |
| Kinoshita, K; Matsuoka, Y; Watanabe, Y; Yamamura, M | 1 |
| Errante, L; Gardon, M; Mugnaini, E; Sekerkova, G; Shaw, G; Tang, D | 1 |
| Adachi, K; Izumi, M; Li, M; Mitsuma, T; Osano, H; Rhue, BN | 1 |
| Clark, BR; Tolbert, DL | 1 |
| CIOTTI, MM; GOLDIN, A; HUMPHREYS, SR; KAPLAN, NO; VENDITTI, JM | 1 |
| CLARK, EM; LANDAUER, W | 1 |
| BRUNNEMANN, A; COPER, H; HERKEN, H | 1 |
| SEKI, S | 1 |
| HERKEN, H; NEUHOFF, V; WILLING, F | 1 |
| BRUNNEMANN, A; COPER, H | 1 |
| Saxon, DW; White, G | 1 |
| Cai, AL; Sheline, CT; Zipfel, GJ | 1 |
| BRAUN, K | 1 |
| Dutcher, SK; Kwan, AL; Lin, H | 1 |
| Antilla, JC; Bickford, PC; Engberg, ME; Hudson, CE; Kang, CW; Lambert, CS; Philpot, RM; Rowell, PP; Wecker, L; Zesiewicz, TA | 1 |
| Engberg, ME; Johns, BE; Lambert, CS; Philpot, RM; Wecker, L | 1 |
| Engberg, ME; Johns, BE; Marrero-Rosado, B; Philpot, RM; Wecker, L | 1 |
26 other study(ies) available for 3-acetylpyridine and niacinamide
| Article | Year |
|---|---|
Niacinamide blocks 3-acetylpyridine toxicity of cerebellar granule cells in vitro.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cerebellum; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Mazindol; N-Methylaspartate; Neurons; Niacinamide; Pyridines; Rats; Rats, Sprague-Dawley; Selegiline; Tetrahydrofolates | 1992 |
Effect of 3-acetylpyridine on serotonin uptake and release from rat cerebellar slices.
Topics: Animals; Calcium; Cerebellar Cortex; Cerebellum; Harmaline; In Vitro Techniques; Kinetics; Niacinamide; Potassium; Pyridines; Rats; Serotonin | 1991 |
Niacinamide transport through the blood-brain barrier.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain; Capillary Permeability; Niacinamide; Pyridines; Rats; Rats, Inbred Strains | 1987 |
Central neurotoxic effects of intraperitoneally administered 3-acetylpyridine, harmaline and niacinamide in Sprague-Dawley and Long-Evans rats: a critical review of central 3-acetylpyridine neurotoxicity.
Topics: Animals; Brain Diseases; Corpus Striatum; Harmaline; Hippocampus; Limbic System; Male; Medulla Oblongata; Mesencephalon; Niacinamide; Olivary Nucleus; Pyridines; Rats; Rats, Inbred Strains; Substantia Nigra | 1985 |
Influence of nicotinamide on neurobehavioral effects of 3-acetylpyridine.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Locomotion; Male; Motor Activity; Motor Skills; Muridae; Muscle Tonus; Niacinamide; Pyridines; Reflex | 1982 |
Actions of 6-aminonicotinamide on benzodiazepine receptors in rat CNS.
Topics: 6-Aminonicotinamide; Animals; Cerebral Cortex; Diazepam; Harmaline; Male; Niacinamide; Pyridines; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A | 1983 |
Are the climbing fibres essential for the Purkinje cell inhibitory action?
Topics: Animals; Cerebellum; Harmaline; Neurons; Niacinamide; Olivary Nucleus; Purkinje Cells; Pyridines; Rats | 1981 |
Effect of administration of 3-acetylpyridine followed by niacinamide injection on survival, extent of the inferior olivary complex lesion, and response to harmaline in the young rat.
Topics: Animals; Brain; Harmaline; Injections, Intraperitoneal; Niacinamide; Olivary Nucleus; Pyridines; Rats; Rats, Inbred Strains; Tremor | 1994 |
Nicotinamide analogs and DNA-damaging agents deplete thyroid hormone receptor and c-erbA mRNA levels in pituitary GH1 cells.
Topics: Adenosine Diphosphate Ribose; Animals; Cell Line; DNA Damage; Enzyme Activation; Gene Expression; NAD; Niacinamide; Pituitary Gland; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins; Pyridines; Rats; Receptors, Thyroid Hormone; RNA, Messenger | 1993 |
TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats.
Topics: Animals; Cerebellar Ataxia; Male; Motor Activity; Niacinamide; Pyridines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone | 1998 |
The intermediate filament protein peripherin is a marker for cerebellar climbing fibres.
Topics: Animals; Biomarkers; Cerebellum; Intermediate Filament Proteins; Membrane Glycoproteins; Microscopy, Immunoelectron; Nerve Fibers; Nerve Tissue Proteins; Niacinamide; Peripherins; Pyridines; Rats; Rats, Sprague-Dawley; Staining and Labeling | 1998 |
Thyrotropin-releasing hormone and its receptor in the cerebellum of inferior olive destroyed rat brain.
Topics: Animals; Ataxia; Cell Count; Denervation; Harmaline; Immunohistochemistry; Male; Neurotoxins; Niacinamide; Olivary Nucleus; Purkinje Cells; Pyridines; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone | 2000 |
Olivocerebellar projections modify hereditary Purkinje cell degeneration.
Topics: Animals; Behavior, Animal; Calbindins; Cell Survival; Cerebellar Cortex; Denervation; Disease Models, Animal; Harmaline; Male; Nerve Degeneration; Neural Pathways; Neurotoxins; Niacinamide; Olivary Nucleus; Parvalbumins; Purkinje Cells; Pyridines; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Rats, Wistar; S100 Calcium Binding Protein G; Spinocerebellar Degenerations | 2000 |
Significance of enzymatically catalyzed exchange reactions in chemotherapy.
Topics: Animals; Coenzymes; Liver; Mice; Neoplasms; Niacin; Niacinamide; Nicotinic Acids; Pyridines; Tryptophan | 1954 |
The interaction in teratogenic activity of the two niacin analogs 3-acetylpyridine and 6-aminonicotinamide.
Topics: 6-Aminonicotinamide; Antimetabolites; Congenital Abnormalities; Embryo, Mammalian; Embryo, Nonmammalian; Niacin; Niacinamide; Pyridines; Teratogens | 1962 |
[BIOSYNTHESIS OF 3-ACETYLPYRIDINE-ADENINEDINUCLEOTIDEPHOSPHATE (3-APADP) FROM NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (NADP)].
Topics: Adenine; Brain; NADP; Niacinamide; Nucleotides; Phosphates; Pyridines | 1963 |
EFFECTS OF NICOTINAMIDE, ISONICOTINIC ACID HYDRAZIDE, AND 3-ACETYLPYRIDINE ON THE GROWTH AND NICOTINAMIDE ADENINE DINUCLEOTIDE CONTENT OF L CELLS.
Topics: Alcohol Oxidoreductases; Cell Division; Isoniazid; NAD; NADP; Niacin; Niacinamide; Pharmacology; Pyridines; Research; Research Design; Tissue Culture Techniques | 1963 |
[THE EXCHANGE BETWEEN 3-ACETYLPYRIDINE AND NICOTINAMIDE IN THE PYRIDINE NUCLEOTIDES IN DIFFERENT REGIONS OF THE BRAIN].
Topics: Brain; Brain Chemistry; Fluorometry; Metabolism; NAD; NADP; Niacin; Niacinamide; Nucleotides; Pyridines; Rats; Research; Spectrum Analysis | 1964 |
[COMPARATIVE STUDIES ON THE BIOSYNTHESIS OF NAD(P)-ANALOGS OF 3-ACETYLPYRIDINE, 4-ACETYLPYRIDINE, 6-AMINONICOTINAMIDE AND ISONICOTINIC ACID HYDRAZIDE].
Topics: 6-Aminonicotinamide; Brain; Isoniazid; NAD; Niacin; Niacinamide; Pyridines; Rats; Research | 1964 |
Episodic vestibular disruption following ablation of the inferior olive in rats: behavioral correlates.
Topics: Animals; Autonomic Nerve Block; Behavior, Animal; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Male; Neurotoxins; Niacinamide; Olivary Nucleus; Poisons; Pyridines; Rats; Rats, Sprague-Dawley; Reflex, Vestibulo-Ocular; Silver Staining; Tetrodotoxin; Vestibular Diseases; Vestibulocochlear Nerve | 2006 |
Zinc neurotoxicity is dependent on intracellular NAD levels and the sirtuin pathway.
Topics: Aldehydes; Animals; Antioxidants; Brain Ischemia; Cells, Cultured; Flavonoids; Flavonols; Ion Channels; Male; Mitochondria; NAD; Naphthalenes; Neural Conduction; Neurotoxicity Syndromes; Neurotoxins; Niacinamide; Pyridines; Rats; Rats, Long-Evans; Resveratrol; Signal Transduction; Sirtuins; Stilbenes; Transcriptional Activation; Zinc | 2006 |
The effect of 3-acetylpyridine and niacinamide on the perfused heart.
Topics: Niacin; Niacinamide; Nicotinic Acids; Pyridines | 1949 |
Synthesizing and salvaging NAD: lessons learned from Chlamydomonas reinhardtii.
Topics: Amino Acid Sequence; Animals; Aspartic Acid; Base Sequence; Biological Evolution; Biosynthetic Pathways; Chlamydomonas reinhardtii; Gene Expression Regulation; Gene Expression Regulation, Plant; Genes, Plant; Mammals; Molecular Sequence Data; Mutagenesis, Insertional; Mutation; NAD; Niacinamide; Nicotinamide-Nucleotide Adenylyltransferase; Phenotype; Plant Proteins; Pyridines; Time Factors; Transcription, Genetic | 2010 |
Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
Topics: Animals; Ataxia; Benzazepines; Cerebellum; Dose-Response Relationship, Drug; Gait; Male; Mecamylamine; Motor Activity; Nerve Degeneration; Neural Pathways; Niacinamide; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Olivary Nucleus; Postural Balance; Pyridines; Quinoxalines; Rats; Rotarod Performance Test; Varenicline | 2013 |
Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments.
Topics: Animals; Ataxia; Biomechanical Phenomena; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Gait; Male; Niacinamide; Nicotinic Agonists; Olivary Nucleus; Principal Component Analysis; Pyridines; Random Allocation; Rats, Sprague-Dawley; Varenicline; Walking | 2015 |
3-Acetylpyridine neurotoxicity in mice.
Topics: Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Gait; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurotoxicity Syndromes; Neurotoxins; Niacinamide; Phosphopyruvate Hydratase; Postural Balance; Psychomotor Disorders; Pyridines; Species Specificity; Time Factors; Vitamin B Complex | 2017 |